PACB Pacific Biosciences of California, Inc.

NASDAQ
$2.24

Pacific Biosciences of California, Inc. (PACB) Earnings News

Earnings press releases, previews and reviews for Pacific Biosciences of California, Inc. (PACB), newest first. Our most recent is review: PacBio Beats on Sequential Rebound and Deep Cost Cuts, but Another Guidance Trim and Margin Squeeze Keep the Inflection Story Unproven.